HealthEquity (NASDAQ: HQY) reported Q2 EPS of $0.53, $0.05 better than the analyst estimate of $0.48. Revenue for the quarter came in at $243.5 million versus the consensus estimate of $240.06 million.

GUIDANCE:

HealthEquity sees FY2024 EPS of $1.97-$2.06, versus the consensus of $1.92. HealthEquity sees FY2024 revenue of $980-990 million, versus the consensus of $981.07 million.

For earnings history and earnings-related data on HealthEquity (HQY) click here.